Yumiko Mashimo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yumiko Mashimo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Akiko Shichishima-Nakamura
Department of Hematology, Fukushima Medical University, Fukushima, Japan
1 shared publication - Alain Mayindu Ngoma
Centre intégré de santé et de services sociaux de l'Outaouais Quebec Canada
1 shared publication - Hiroshi Ohkawara
Department of Hematology, Fukushima Medical University, Fukushima, Japan
1 shared publication - Hiroshi Takahashi
Department of Hematology, Fukushima Medical University, Fukushima, Japan
1 shared publication - Hitoshi Ohto
Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima 960-1295, Japan
1 shared publication - Kazuei Ogawa
Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan
1 shared publication
Latest Publications
- Open Access
- 26 July 2015
- Published by Springer Nature in Biological Research
- Vol. 48 (1) , 1-8
CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
CD4+CD25highFOXP3+ regulatory T (Treg) cells, which include thymus-derived and peripherally induced cells, play a central role in immune regulation, and are therefore crucial to prevent graft-versus-host disease (GVHD). The increasing use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for elderly patients with thymus regression, and our case of allo-HSCT shortly after total thymectomy, raised questions about the activity of thymus-derived Treg cells and peripherally induced Treg cells, which are otherwise indistinguishable. We found that despite pre-transplant thymectomy or older age, both naïve and effector Treg cells, as well as naïve and effector conventional T cells, proliferated in allo-HSCT recipients. Higher proportions of total Treg cells 1 month post allo-HSCT, and naïve Treg cells 1 year post allo-HSCT, appeared in patients achieving complete chimera without developing significant chronic GVHD, including our thymectomized patient, compared with patients who developed chronic GVHD. Treg cells that modulate human allogeneic immunity may arise peripherally as well as in the thymus of allo-HSCT recipients.
- 26 July 2015
- Published by Springer Nature in Biological Research
- Vol. 48 (1) , 1-8
Open AccessCD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
CD4+CD25highFOXP3+ regulatory T (Treg) cells, which include thymus-derived and peripherally induced cells, play a central role in immune regulation, and are therefore crucial to prevent graft-versus-host disease (GVHD). The increasing use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for elderly patients with thymus regression, and our case of allo-HSCT shortly after total thymectomy, raised questions about the activity of thymus-derived Treg cells and peripherally induced Treg cells, which are otherwise indistinguishable. We found that despite pre-transplant thymectomy or older age, both naïve and effector Treg cells, as well as naïve and effector conventional T cells, proliferated in allo-HSCT recipients. Higher proportions of total Treg cells 1 month post allo-HSCT, and naïve Treg cells 1 year post allo-HSCT, appeared in patients achieving complete chimera without developing significant chronic GVHD, including our thymectomized patient, compared with patients who developed chronic GVHD. Treg cells that modulate human allogeneic immunity may arise peripherally as well as in the thymus of allo-HSCT recipients.